EHR

Premier Orthopaedic and Hand Center Selects eClinicalWorks Cloud EHR and healow for Faster, More Efficient Workflows

eClinicalWorks Scribe and healow solutions to assist the specialty center in reducing provider burnout and maximizing savingsWESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the...

NextGen Healthcare Expands Global Footprint to Support Healthcare Organizations with Advanced Interoperability Solutions

Mirth® Connect by NextGen Healthcare Adopted by Strategic Reseller PartnersREMOTE-FIRST COMPANY/NEW YORK--(BUSINESS WIRE)--#NextGenHealthcare--NextGen Healthcare, Inc., a leading provider of innovative,...

Boehringer Ingelheim licenses multiple Dark Antigens® from Enara Bio to develop off-the-shelf immunotherapies for non-small cell lung cancer (NSCLC)

Licensed antigens are shared across major subsets of NSCLC and have confirmed presence on the surface of tumor cells, homogeneous...

New England Orthopedic Surgeons Selects athenahealth to Transform Patient Experience, Optimize Performance, and Support Continued Growth

Leading orthopedic provider adopting athenaOne® for its value as a modern and comprehensive suite of EHR, practice management, and patient...

4DMT and Arbor Biotechnologies Establish Partnership to Co-Develop and Co-Commercialize Next-Generation Genetic Medicines for CNS Diseases

Partnership brings together two leaders in next-generation genetic medicines to engineer, co-develop and co-commercialize (50:50 profit share) AAV-delivered CRISPR/Cas-based therapeutics...

4DMT and Arbor Biotechnologies Establish Partnership to Co-Develop and Co-Commercialize Next-Generation Genetic Medicines for CNS Diseases

Partnership brings together two leaders in next-generation genetic medicines to engineer, co-develop and co-commercialize (50:50 profit share) AAV-delivered CRISPR/Cas-based therapeutics...

Virios Therapeutics, Inc. Reaches Alignment with FDA on Requirements for Advancing Development Candidate IMC-2 as Treatment for Long-COVID

ATLANTA, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on developing...

SeaStar Medical Updates Subject Enrollment in its Pivotal Trial with the Selective Cytopheretic Device in Adults with Acute Kidney Injury

DENVER, Dec. 28, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions...

error: Content is protected !!